September 16th, 2022
•The liquid biopsy has revolutionized our approach to oncology translational studies, with sample collection, quality, and storage being crucial steps for its successful clinical application. Here we describe a standardized and validated protocol for downstream circulating-free DNA applications that can be applied in most translational research laboratories.
Related Videos
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization
Moving Upwards: A Simple and Flexible In Vitro Three-dimensional Invasion Assay Protocol
Characterizing DNA Repair Processes at Transient and Long-lasting Double-strand DNA Breaks by Immunofluorescence Microscopy
Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Automated Dissection Protocol for Tumor Enrichment in Low Tumor Content Tissues
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved